Hong Kong Pharmaceuticals & Biotech Upcoming Dividends

Essex Bio-Technology

Market Cap: HK$1.3b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Jacobson Pharma

Market Cap: HK$2.1b

Through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally.

JBM (Healthcare)

Market Cap: HK$1.5b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.